[HTML][HTML] Metformin prevents nigrostriatal dopamine degeneration independent of AMPK activation in dopamine neurons

JA Bayliss, MB Lemus, VV Santos, M Deo, JS Davies… - PloS one, 2016 - journals.plos.org
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …

[PDF][PDF] Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons

JA Bayliss, MB Lemus, VV Santos, M Deo, JS Davies… - PLoS ONE, 2016 - core.ac.uk
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …

[PDF][PDF] Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons

JA Bayliss, MB Lemus, VV Santos, M Deo… - PLoS …, 2016 - research.monash.edu
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …

Metformin prevents nigrostriatal dopamine degeneration independent of AMPK activation in dopamine neurons

JA Bayliss, MB Lemus, VV Santos, M Deo, JS Davies… - PLoS ONE, 2016 - go.gale.com
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …

Metformin prevents nigrostriatal dopamine degeneration independent of AMPK activation in dopamine neurons

JA Bayliss, MB Lemus, V Santos, M Deo… - PLoS …, 2016 - acuresearchbank.acu.edu.au
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …

[引用][C] Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons

JA Bayliss, MB Lemus, VV Santos, M Deo… - PLoS …, 2016 - ui.adsabs.harvard.edu
Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in
Dopamine Neurons - NASA/ADS Now on home page ads icon ads Enable full ADS view …

[引用][C] Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons

JA Bayliss, MB Lemus, VV Santos, M Deo, JS Davies… - PLOS ONE, 2016 - cir.nii.ac.jp
Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in
Dopamine Neurons | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細 …

Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons.

JA Bayliss, MB Lemus, VV Santos, M Deo, JS Davies… - Plos one, 2016 - europepmc.org
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …

[HTML][HTML] Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons

JA Bayliss, MB Lemus, VV Santos, M Deo, JS Davies… - PLoS ONE, 2016 - ncbi.nlm.nih.gov
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …

[PDF][PDF] Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons

JA Bayliss, MB Lemus, VV Santos, M Deo… - PLoS …, 2016 - pdfs.semanticscholar.org
Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …